Surveillance and disease data for tuberculosis
Surveillance is a crucial component in the control and elimination of TB in the European Union and European Economic Area. An accurate overview of the TB situation enables the strengths of TB control to be identified and the remaining challenges to be addressed. Together with the World Health Organization’s Regional Office for Europe, ECDC collects and disseminates TB surveillance data for the European region.
Whole genome sequencing for molecular typing and characterisation of Mycobacterium tuberculosis
ECDC has initiated a 30-month (2017–2020) pilot project on the use of whole genome sequencing (WGS) for molecular typing and characterisation of M. tuberculosis in the EU/EEA. The pilot project is led by four European Research and Public Health Institutes (Ospedale San Raffaele, Forschungszentrum Borstel, National Institute for Public Health and the Environment and Public Health England), with extensive expertise on the use of WGS for M. tuberculosis complex strain characterisation and operational aspects for optimal implementation of WGS-based TB epidemiological surveillance.
Monitoring and evaluation
ECDC analyses trends in TB notification rates across the EU/EEA to assess how the region is progressing towards TB elimination. The performance of countries in tackling TB is monitored using the indicators of the ‘Roadmap to implement the tuberculosis action plan for the WHO European Region 2016–2020’.
Disease data from ECDC Surveillance Atlas - tuberculosis
The Surveillance Atlas of Infectious Diseases is a tool that interacts with the latest available data about a number of infectious diseases. The interface allows users to interact and manipulate the data to produce a variety of tables and maps.
ECDC and WHO Regional Office for Europe Tuberculosis fact sheet 2018
This fact sheet was created in collaboration with WHO Regional office for Europe to provide basic information on tuberculosis ahead of the United Nations High-Level Meeting on Tuberculosis 26th September 2018.
The burden of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB
This infographic shows the burden in the EU of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB based on data from the 2014 surveillance report